The French National Cochlear Implant Registry (EPIIC): Cochlear implantation in adults over 65years old.


Journal

European annals of otorhinolaryngology, head and neck diseases
ISSN: 1879-730X
Titre abrégé: Eur Ann Otorhinolaryngol Head Neck Dis
Pays: France
ID NLM: 101531465

Informations de publication

Date de publication:
Sep 2020
Historique:
pubmed: 11 8 2020
medline: 9 9 2021
entrez: 11 8 2020
Statut: ppublish

Résumé

To analyze the performance of cochlear implants in French patients aged 65 and over, implanted between 2012 and 2016, using data from the French national registry for cochlear implants (EPIIC). The French national registry incorporates patient data from before implantation and for three years after implantation, stratified in different age groups (18-39, 40-64years, 65-74years and>75years). Here, we assessed the latter two categories. Hearing was assessed using mono- and disyllabic words in a silent background. The Category of Auditory Performance (CAP) scale was also implemented and subjects took the Abbreviated Profile of Hearing Aid Benefit (Aphab) questionnaire. The population aged over 65 accounted for 38% (n=1193) of the 3178 adult implanted patients. The performance for mono- and disyllabic words in silence, the CAP scores and the APHAB questionnaire answers for ease of communication, background noise and reverberation were dramatically improved at one year post-implantation (P<0.0001 for each score) and remained stable between one and three years thereafter. The percentage improvement was similar across all age groups. The scores for loud-noise intolerance did not change after cochlear implantation in any age group. Cochlear implants improve hearing and communication in subjects aged 65 and over, with comparable efficiency to that achieved in younger subjects. Cochlear implantation should thus be proposed whenever hearing aids provide only limited benefit. However, between 2012 and 2016, cochlear implantation was given to less than 1% of the French population aged 65 and over with profound deafness.

Identifiants

pubmed: 32773333
pii: S1879-7296(20)30177-0
doi: 10.1016/j.anorl.2020.07.011
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

S19-S25

Informations de copyright

Copyright © 2020 Elsevier Masson SAS. All rights reserved.

Auteurs

I Mosnier (I)

AP-HP Sorbonne Université, Groupe hospitalier Pitié-Salpêtrière, Unité Fonctionnelle Implants auditifs et explorations fonctionnelles, Service ORL, 47-83, boulevard de l'Hôpital, 75651 Paris cedex 13, France. Electronic address: isabelle.mosnier@aphp.fr.

E Ferrary (E)

AP-HP Sorbonne Université, Groupe hospitalier Pitié-Salpêtrière, Unité Fonctionnelle Implants auditifs et explorations fonctionnelles, Service ORL, 47-83, boulevard de l'Hôpital, 75651 Paris cedex 13, France.

K Aubry (K)

CHU de Limoges, Limoges, France.

P Bordure (P)

CHU de Nantes, Nantes, France.

A Bozorg-Grayeli (A)

CHU de Dijon, Dijon, France.

O Deguine (O)

CHU de Toulouse, Toulouse, France.

C Eyermann (C)

CHU de Strasbourg, Strasbourg, France.

V Franco-Vidal (V)

CHU de Bordeaux, Bordeaux, France.

B Godey (B)

CHU de Rennes, Rennes, France.

N Guevara (N)

CHU de Nice, Nice, France.

A Karkas (A)

CHU de Saint-Étienne, Saint-Étienne, France.

N Klopp (N)

CHU d'Amiens, Amiens, France.

M Labrousse (M)

CHU de Reims, Reims, France.

J-P Lebreton (JP)

CHU de Poitiers, Poitiers, France.

Y Lerosey (Y)

CHU de Rouen, Rouen, France.

E Lescanne (E)

CHU de Tours, Tours, France.

N Loundon (N)

Hôpital Necker, Paris, France.

R Marianowski (R)

CHU de Brest, Brest, France.

F Merklen (F)

CHU de Montpellier, Montpellier, France.

K Mezouaghi (K)

CH de La Réunion, La Réunion. Electronic address: kmezouaghi@irsam.fr.

T Mom (T)

CHU de Clermont-Ferrand, Clermont-Ferrand, France.

S Moreau (S)

CHU de Caen, Caen, France.

N Noël-Petroff (N)

Hôpital Robert-Debré, Paris, France.

C Parietti-Winkler (C)

CHU de Nantes, Nantes, France.

P Piller (P)

CH de Nouméa, Nouméa, Nouvelle-Calédonie.

C Poncet (C)

Hôpital Rothschild, Paris, France.

E Radafy (E)

CH du Lamentin, Martinique, Guadeloupe.

S Roman (S)

CHU de Marseille, Marseille, France.

S Roux-Vaillard (S)

CHU d'Angers, Angers, France.

S Schmerber (S)

CHU de Grenoble, La Tronche, France.

L Tavernier (L)

CHU de Besançon, Besançon, France.

E Truy (E)

CHU de Lyon, Lyon, France.

C Vincent (C)

CHU de Lille, Lille, France.

O Sterkers (O)

AP-HP Sorbonne Université, Groupe hospitalier Pitié-Salpêtrière, Unité Fonctionnelle Implants auditifs et explorations fonctionnelles, Service ORL, 47-83, boulevard de l'Hôpital, 75651 Paris cedex 13, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH